UK moves ahead with sweeping veterinary pricing reforms

The UK veterinary market is heading into a new regulatory era after the Competition and Markets Authority concluded its long-running investigation with a final reform package aimed at lowering friction, improving transparency, and helping pet parents navigate rising care costs. In its March 24, 2026 decision, the CMA said weak competition and poor consumer information have left pet parents “in the dark,” and it paired that finding with legally binding remedies that will start coming into force later this year. (gov.uk)

This outcome has been building since the CMA launched a call for information in September 2023, escalated to a formal market investigation in May 2024, and spent the next two years reviewing pricing, medicines, ownership concentration, out-of-hours arrangements, and consumer decision-making across the pet care market. The UK government then added a parallel policy track in January 2026, opening consultation on the first major reform of the Veterinary Surgeons Act in about 60 years after the CMA found that problems in the market could cost households up to £1 billion over five years and that vet fees had risen at nearly twice the rate of inflation. (gov.uk)

The CMA’s final remedies are detailed and operational. Practices will have to publish more complete standard price lists covering consultations, common procedures, diagnostics, written prescriptions, and cremation options. Corporate ownership will have to be disclosed clearly at premises and online. Practices must provide written estimates in advance for treatments expected to cost £500 or more, except in emergencies, and itemized bills afterward. Pet parents must be told they can request a written prescription to shop elsewhere, and those prescription fees are now capped at £21 for the first medicine and £12.50 for each additional medicine. Pet care plans must spell out component pricing and claimed savings, and out-of-hours providers will face limits on unreasonably long notice periods that make it hard for practices to switch vendors. The CMA also said the RCVS will run a comparison service and support compliance, with the setup and ongoing work funded by a levy on veterinary businesses. (gov.uk)

The final package appears somewhat more targeted than some earlier fears in the market. The CMA says the reforms are meant to strengthen trust in the profession and protect clinical judgment from undue commercial pressure, not simply force price competition at any cost. Charitable providers also secured an important carveout: PDSA said it welcomed the final report, particularly the exemption for charities providing small-animal veterinary services, after warning that some proposed remedies could have diverted limited funds away from care delivery. (gov.uk)

Reaction across the sector has been broadly supportive, though not uncritical. The RCVS has backed broader Veterinary Surgeons Act reform as a “once-in-a-generation opportunity” to create a modern regulatory framework, while Which? said the current regime is decades out of date and argued the government should go further by creating a mandatory ombudsman with binding powers over complaints. Animal welfare charities including the RSPCA and Blue Cross also welcomed clearer pricing and stronger oversight, framing the changes as both a consumer-protection and animal-welfare issue. (gov.uk)

Why it matters: For veterinary professionals, especially practice leaders, the significance is in the operational detail. These remedies will likely require changes to client communications, website governance, consent and estimate workflows, prescription protocols, pet plan design, cremation disclosures, complaints handling, and staff training on ownership and pricing transparency. For multi-site groups, the burden may be manageable through centralized systems. For smaller practices, the compliance lift could be proportionally heavier, especially if new levies and administrative requirements arrive before efficiencies do. At the same time, the reforms may help practices that already prioritize transparency by making those standards market-wide, reducing suspicion around pricing and corporate affiliation, and reinforcing the profession’s claim to independent clinical judgment. That combination could matter well beyond the UK if other regulators begin treating veterinary affordability as a competition and consumer-disclosure issue rather than solely a professional-regulation issue. (gov.uk)

What to watch: Near term, watch the CMA’s remedy timetable and the rollout of changes at large-group practices before the end of 2026; longer term, the bigger structural question is whether Defra turns its January 2026 consultation into legislation that extends formal licensing and oversight from individual clinicians to veterinary businesses themselves. (gov.uk)